EUVIMEDEUVIMED entdecken
Klinische StudieOpen Access · CC BY 4.0

Universal capillary screening for chronic autoimmune, metabolic and cardiovascular diseases: feasibility and acceptability of the UNISCREEN study

Sara Angiulli, Aurora Merolla, Elisa Borgonovo, Rebecca De Lorenzo, Serena Spadoni, Barbara Fontana, Giuseppina Manganaro, Elena Rela, Alberto Bongiovanni, Rita Peracino, Chiara Bellino, Giulia Pata und 6 weitere

Frontiers in Public Health · 2025

DOI: 10.3389/fpubh.2025.1506240 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift Frontiers in Public Health, 2025. Verfasst von Sara Angiulli und 17 weiteren Autor:innen. Beteiligte Einrichtung: Vita-Salute San Raffaele University, Milan, Italy. Hauptthemen laut MEDLINE: Autoimmune Diseases, Cardiovascular Diseases, Mass Screening, Metabolic Diseases. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

UNISCREEN is a general population study aiming at evaluating feasibility and acceptability of universal screening for chronic autoimmune (type 1 diabetes and celiac disease) and metabolic/cardiovascular diseases (dysglycemia, type 2 diabetes, dyslipidemia, hypertension) across all age groups using capillary blood sampling by fingerprick to measure disease risk markers.

Methods

UNISCREEN was conducted in the Cantalupo fraction, Cerro Maggiore, Milan, Italy, counting 3,061 inhabitants between 1 and 100 years of age. Participation was voluntary, following a public call. Participants were invited to respond to feasibility and acceptability questionnaires immediately before and after the screening procedures, which included the following: capillary blood drawing for immediate measurement of metabolic parameters (glucose, glycated hemoglobin, total-, HDL- and calculated LDL-cholesterol, triglycerides) and late autoantibody assays; blood pressure measurement; brief consultation with a physician providing feed-back on immediate results and health recommendations. The study was registered as ClinicalTrials.gov NCT05841719.

Results

The study included 1,535 participants (50.1% of local population). A single fingerprick was sufficient for all measurements in 47.1% of cases, while up to two were necessary in 86.9% of cases. Complete glucose and lipid panels were obtained in 1382 participants (90.0%). Sufficient serum for late autoantibody testing was obtained in 99.7% of participants. The questionnaires showed overall satisfaction, with over 90% of participants considering capillary sampling simple and practical, and preferring it to venous sampling. Before screening, 24.0% adults and 31.7% children’s parents were worried about the possibility of being diagnosed or identified as being at risk; worries decreased to 21.3 and 23.4%, respectively, after medical consultation. The immediacy of some result communication possibly contributed to reducing the anticipatory anxiety.

Conclusion

The UNISCREEN study shows that universal screening for chronic autoimmune, metabolic and cardiovascular diseases in the general population using capillary blood testing is feasible and acceptable.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Autoimmune DiseasesCardiovascular DiseasesMass ScreeningMetabolic DiseasesAdolescentAdultAgedAged, 80 and overChildChild, PreschoolFemaleHumansInfantMaleMiddle AgedYoung AdultDiabetes Mellitus, Type 1Feasibility StudiesItalySurveys and Questionnaires

Stichwörter der Autor:innen

capillary bloodcardiovascular diseasesceliac diseasedyslipidemiafeasibility and acceptabilitypopulation screeningtype 1 diabetestype 2 diabetes

Autor:innen und Institutionen

  • Vita-Salute San Raffaele University, Milan, Italy.
  • Diabetes Research Institute, IRCCS San Raffaele Hospital, Milan, Italy.
  • Fondazione Italiana Diabete (FID), Milan, Italy.
  • Behavioural Science and Health, Institute of Epidemiology & Health Care, University College London, London, United Kingdom.

Zitieren

APA

Angiulli, S., Merolla, A., Borgonovo, E., De Lorenzo, R., Spadoni, S., Fontana, B., Manganaro, G., Rela, E., Bongiovanni, A., Peracino, R., Bellino, C., Pata, G., Bianconi, E., Martinenghi, S., Ulivi, F., Renzi, C., Bosi, E., & UNISCREEN Study Group (2025). Universal capillary screening for chronic autoimmune, metabolic and cardiovascular diseases: feasibility and acceptability of the UNISCREEN study. Frontiers in Public Health. https://doi.org/10.3389/fpubh.2025.1506240

Vancouver

Angiulli S, Merolla A, Borgonovo E, De Lorenzo R, Spadoni S, Fontana B, et al. Universal capillary screening for chronic autoimmune, metabolic and cardiovascular diseases: feasibility and acceptability of the UNISCREEN study. Frontiers in Public Health. 2025. doi:10.3389/fpubh.2025.1506240

BibTeX
@article{Angiulli2025,
  author = {Angiulli, Sara and Merolla, Aurora and Borgonovo, Elisa and De Lorenzo, Rebecca and Spadoni, Serena and Fontana, Barbara and Manganaro, Giuseppina and Rela, Elena and Bongiovanni, Alberto and Peracino, Rita and Bellino, Chiara and Pata, Giulia and Bianconi, Eleonora and Martinenghi, Sabina and Ulivi, Francesca and Renzi, Cristina and Bosi, Emanuele and UNISCREEN Study Group, UNISCREEN Study Group},
  title = {Universal capillary screening for chronic autoimmune, metabolic and cardiovascular diseases: feasibility and acceptability of the UNISCREEN study},
  journal = {Frontiers in Public Health},
  year = {2025},
  doi = {10.3389/fpubh.2025.1506240}
}
Kostenlos starten →